Pulling SEC filings + quote and writing the call…

Norwegian Cruise Line Holdings Ltd.
Next earnings Jul 29, 2026 (before open) · consensus $0.39 EPS, $2.70B rev
Last earnings -8.6% on 2026-05-04
Cruise demand has fully recovered and operations are strong — but a $18B debt load and huge newbuild commitments cap the upside.
Revenue $9.83B · FY2025
Middling fundamentals and a rich price (~63% above fair value) leave little margin of safety — a wait-and-see.
Norwegian Cruise Line is operationally healthy again. FY2025 revenue grew 3.7% to $9.83B, operating income rose 6.5% to $1.56B (a 15.9% operating margin), and the company generated $2.09B of operating cash flow. The post-pandemic recovery is complete on the demand side — revenue has climbed from $648M (FY2021) to $9.83B — and equity grew 55% to $2.21B as the company rebuilds its capital base. Even net income of $423M off a thin 4.3% net margin still produced a 19.2% ROE on that small equity base.
The problem is the balance sheet and the spending ahead. Net income fell 53.5% YoY despite higher operating income, the gap explained by interest expense on a debt load that, including estimated interest, totals roughly $18.1B. Liabilities of $20.3B against $2.21B of equity put leverage at 9.20x, and retained earnings remain deeply negative at -$5.57B from the pandemic. On top of servicing that debt, NCLH has 13 non-cancelable newbuild ships on order with contract prices of roughly $21.5B and capital commitments of about $2.9B in each of 2026 and 2027. Management notes this future capex 'will significantly increase' depreciation and interest, and capex already jumped 169% to $3.26B. Mitigants exist — 90% of debt is fixed-rate and about 80% of each newbuild is funded by committed export-credit facilities ($12.2B undrawn) — but the financial leverage is extreme.
AI-generated analysis, produced by our proprietary engine from SEC filing data.
Investment recommendation produced by TENK/calls (tenkcalls.com), Luxembourg. Completed Jun 21, 2026, 4:51 PM ET. Ratings & methodology: definitions · All recommendations to date: track record · Conflicts: disclosures. Not investment advice.
| Line item | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Revenue | $648M | $4.84B | $8.55B | $9.48B | $9.83B |
| Gross profit | — | — | — | — | — |
| Operating income | -$2.55B | -$1.55B | $931M | $1.47B | $1.56B |
| Net income | -$4.51B | -$2.27B | $166M | $910M | $423M |
| Diluted EPS | -$12.33 | -$5.41 | $0.39 | $1.89 | $0.92 |
| Net margin | -695.5% | -46.9% | 1.9% | 9.6% | 4.3% |
Annual figures from SEC 10-K XBRL filings. Open the filing links below for full statement detail.
Computed from SEC XBRL annual figures + the current quote. EV and ROIC use long-term + current debt where filed; estimates, not investment advice.
Sources: SEC EDGAR (CIK 0001513761, latest 10-Q filed 2026-05-04) · EODHD · Proprietary analysis · as of 6/21/2026, 8:51:49 PM.
Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.
Last 90 days: 10 open-market buys · 0 sales
| 2026-06-02 | PAGLIUCA STEPHEN G Director | Buy | 685K @ $18.06 | $12.4M |
| 2026-06-01 | PAGLIUCA STEPHEN G Director | Buy | 695K @ $18.16 | $12.6M |
| 2026-05-22 | CHIDSEY JOHN President and CEO | Buy | 153K @ $16.37 | $2.50M |
| 2026-05-20 | COHEN JONATHAN Z Director | Buy | 30.0K @ $15.83 | $475K |
| 2026-05-19 | Cil Jose E. Director | Buy | 10.0K @ $14.91 | $149K |
| 2026-05-18 | Cil Jose E. Director | Buy | 5.00K @ $15.25 | $76.3K |
| 2026-05-11 | MacDonald Brian P Director | Buy | 15.0K @ $16.54 | $248K |
| 2026-05-07 | Lansberry Kevin Allen Director | Buy | 11.4K @ $17.28 | $197K |
| 2026-05-07 | Byng-Thorne Zillah Director | Buy | 25.0K @ $17.67 | $442K |
| 2026-05-07 | Byng-Thorne Zillah Director | Buy | 4.45K @ $17.83 | $79.4K |
| 2026-04-13 | MacDonald Brian P Director | Award | 8.91K |
Dates from 8-K (Item 2.02); beat/miss = reported EPS vs consensus (Finnhub, recent quarters); move = prior close → close on/after.
Disclosed under the STOCK Act
Self-reported periodic transaction reports (STOCK Act). Amounts are disclosed ranges; a trade may be a spouse's. Disclosures lag the trade by up to ~45 days. Source: House Clerk + Senate eFD.
Recent news tone vs the market's typical (which skews positive). A soft signal, not a recommendation.